By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
October 31, 2025 12:28 AM EDT
Medical Herald
Search
  • Health Conditions
    Health ConditionsShow More
    Beware of Counterfeit Weight Loss Drugs Sold Online
    Weight Management
    Father’s Back Pain Leads to Tragic Cancer Diagnosis
    Cancer
    Novo Nordisk’s CEO Emphasizes Strategic Risks to Lead Obesity Market
    Weight Management
    Medtronic Launches Ankle Implant for Bladder Control
    Health Conditions
    Stewart’s Caring Place Highlights All Cancer Awareness in October
    Breast Cancer
  • Wellness & Self-Care
    Wellness & Self-CareShow More
    Pureance HydraLift: A Scientific Approach to Hair Care
    Wellness & Self-Care
    Jewel Reflects on Fame and Mental Health Advocacy Journey
    Mental Health
    Discover the Health Benefits of Hazelnuts
    Healthy Living
    How the Government Shutdown Affects Health Insurance Costs
    Wellness & Self-Care
    NYC Sues Tech Giants Over Youth Mental Health Crisis
    Mental Health
  • Nutrition & Fitness
    Nutrition & FitnessShow More
    Delicious Roasted Salmon with Olives from Dan Pelosi
    Healthy Recipes
    Short Exercise Bursts: A New Trend in Fitness?
    Fitness
    PepsiCo Launches Protein-Focused Beverages to Meet Demand
    Diet & Nutrition
    Calcium Loaf: A Depression-Era Recipe for Today’s Food Challenges
    Healthy Recipes
    Effective Full-Body Workout Enhances Testosterone and Muscle
    Fitness
  • Innovation
    InnovationShow More
    Understanding Superspreading and Pathogen Virulence Evolution
    Innovation
    Starkey Launches Innovative AI Hearing Aid for All Generations
    Innovation
    AstraZeneca Boosts Virginia Investment to $4.5 Billion for Drug Production
    Drugs & Medications
    How ALV-J Virus Bypasses Immune Defense Using miR-155
    Innovation
    Nursing Homes’ Use of Painkillers and Antidepressants Raises Risks
    Drugs & Medications
  • News
    NewsShow More
    Diet Coke Lime Set to Return in 2025 After Seven-Year Hiatus
    News
    Dublin Environmentalists Celebrate Tentative Repeal of Measure II
    News
    Trust in CDC Plummets Under Kennedy’s Leadership, Poll Reveals
    News
    St. Joseph Plans New Community Center and Cannabis Dispensary
    News
    Harry and Meghan Shine at World Mental Health Day Gala in NYC
    News
Font ResizerAa
Medical HeraldMedical Herald
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Search
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Follow US
Copyright © 2025, Medical Herald. All Rights Reserved.
Home » Health Conditions » Alzheimer » New Study Links Circadian Protein to Alzheimer’s Treatment

New Study Links Circadian Protein to Alzheimer’s Treatment

By Jessica Monroe
Published: October 10, 2025
Share

A recent study suggests that disrupting the connection between the body’s circadian clock and brain functions may play a significant role in combating neurodegeneration associated with Alzheimer’s disease. Led by Erik Musiek, a neurology professor at Washington University in St. Louis, along with first author Jiyeon Lee and a team of researchers, the study focused on mouse models to explore the effects of a specific circadian protein.

The circadian clock protein in question, known as REV-ERBα, is recognized for its role in regulating daily metabolic and inflammatory rhythms. While this protein has not been extensively studied in the brain, its influence in other tissues indicates it helps control levels of nicotinamide adenine dinucleotide (NAD+), a critical molecule required for various cellular functions, including DNA repair and metabolic processes. Researchers have identified a direct correlation between NAD+ levels and brain health; specifically, lower NAD+ levels are associated with accelerated brain aging and neurodegeneration.

Many commercial supplements claim to boost NAD+ levels as a means to mitigate aging effects. Musiek’s research took a significant step further by examining the impacts of REV-ERBα on NAD+ levels in mouse models.

The study involved two distinct groups of mice: one where REV-ERBα was genetically deleted across all tissues and another where it was specifically deleted in astrocytes—glial cells that constitute a substantial part of the central nervous system. Results showed an increase in NAD+ levels in both groups, underscoring that the absence of REV-ERBα in astrocytes directly affects NAD+ levels in the brain. This discovery opens a potential pathway for future research aimed at treating neurodegenerative diseases.

Moreover, the team further tested the effects of REV-ERBα inhibition through both genetic deletion and a promising new drug that has demonstrated potential benefits in amyloid-β pathology and Parkinson’s disease studies. The findings revealed that inhibiting REV-ERBα led to elevated NAD+ levels and offered protection against tau pathology, a toxic aggregation of proteins that is linked to neurodegenerative diseases such as Alzheimer’s.

These insights suggest that the experimental drug may pave the way for innovative therapeutic approaches to preventing and managing Alzheimer’s disease.

The results of this pivotal research have been published in the esteemed journal, Nature Aging. The study not only highlights the intricate relationship between circadian rhythms and brain health but also sets the stage for exploring novel treatments that could significantly alter the landscape of Alzheimer’s disease management in the future.Diseases & Conditions

TAGGED:AlzheimerCircadian Protein
Share This Article
Facebook LinkedIn Email Copy Link
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

HOT NEWS

Diet Coke Lime Set to Return in 2025 After Seven-Year Hiatus

October 30, 2025

Understanding Superspreading and Pathogen Virulence Evolution

Superspreading alters how pathogens evolve, influencing virulence, transmission, and long-term epidemic behavior across diverse host…

October 30, 2025

Dublin Environmentalists Celebrate Tentative Repeal of Measure II

A judge ruled Dublin must conduct an environmental review of Measure II, a controversial plan…

October 30, 2025

Delicious Roasted Salmon with Olives from Dan Pelosi

Dan Pelosi’s roasted salmon with Castelvetrano olives and orange zest blends freshness, simplicity, and flavor…

October 30, 2025

YOU MAY ALSO LIKE

Study Links Air Pollution to Cognitive Decline and Alzheimer’s Risk

New research from Penn Medicine links fine particulate air pollution to accelerated Alzheimer’s progression and worsening cognitive symptoms.

October 17, 2025

Breakthrough ‘AstroCapsules’ May Combat Alzheimer’s and Parkinson’s

AstroCapsules, a novel cell therapy using human astrocytes, show promise in reducing brain inflammation linked to Alzheimer’s and Parkinson’s disease.

October 1, 2025

Breakthrough in Mice Shows Promise for Reversing Alzheimer’s

Repairing the brain’s “gatekeeper” cleared toxic proteins and restored memory in mouse models—hinting at a new path toward future Alzheimer’s…

October 9, 2025

Medical Herald is your trusted source for medical news, scientific research, health policy updates, and expert insights from around the world. 

Category

  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
  • Privacy Policy
  • About Us
  • Contact

Follow US: 

  • Grow Big Agency Sites:
  • London Business Journal
Copyright © 2025, Medical Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?